The short answer
The additional bleeding risk from chondroitin sulfate with pentoxifylline is uncertain. Review the exact product and your bleeding risk factors with your prescriber.
What this answer covers
Oral chondroitin sulfate products with oral extended-release pentoxifylline. Exact formulation and clinical setting matter; aspirin, warfarin and other medicines are not interchangeable.
- Supplement or preparation
- Chondroitin sulfate
- Medication ingredient
- pentoxifylline
What the original evidence shows
An original report described a higher INR after a warfarin user increased a combined glucosamine and chondroitin product. The accompanying reports mainly concerned glucosamine or combination products. They did not isolate chondroitin, and warfarin is a different medicine from pentoxifylline.
Pentoxifylline’s own evidence matters
Bleeding has been reported with pentoxifylline, including in people taking other medicines that affect bleeding. However, a small randomized study in patients with diabetes and coronary disease found no extra platelet inhibition when pentoxifylline was added to aspirin and clopidogrel. This does not exclude rare bleeding, but it limits blanket assumptions about additive effects.
Review the actual supplement
Check whether the product contains glucosamine, other joint ingredients or additional herbs. If you also take warfarin, tell its monitoring team about starting, stopping or changing the supplement. That separate concern does not establish that chondroitin alone interacts with pentoxifylline or that a two-hour gap helps.
Use a monitoring plan, not an untested spacing rule
The label recommends assessment for bleeding in people with risk factors such as recent surgery or ulcer disease. Tell your prescriber about unusual bruising, persistent nosebleeds or other new bleeding; substantial or ongoing bleeding needs prompt care. No supplement-specific hours-apart schedule has been shown to prevent these concerns, and you should not change pentoxifylline yourself.
Evidence and practical considerations
Side effects & toxicity
An increased bleeding rate specifically from chondroitin sulfate with pentoxifylline has not been established.
- Exact scope
- Oral chondroitin sulfate products with oral extended-release pentoxifylline. Exact formulation and clinical setting matter; aspirin, warfarin and other medicines are not interchangeable. with Exact pentoxifylline RxCUI 8013 IN confirmed by current RxNorm. Oral extended-release 400 mg tablets for intermittent claudication; experimental immediate-release, intravenous and other-drug exposures are distinct.
- Medication form and route
- Oral
What remains uncertain
- Available other-drug, short-duration and surrogate-endpoint findings do not quantify this exact pair’s clinical bleeding risk. No validated protective dose separation.
Factors that may matter: Exact preparation and dose; Fasting versus fed dosing; Bleeding and ulcer history; Other medicines.
Read the supporting source summaries
Source 1: Current prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Adults with intermittent claudication due to chronic occlusive arterial disease.
Bleeding reported with or without NSAIDs, anticoagulants or platelet inhibitors. Prior methylxanthine intolerance, including caffeine, is a contraindication. Pentoxifylline can raise theophylline levels; strong CYP1A2 inhibitors can raise pentoxifylline exposure.
How this applies: Exact drug/formulation guidance. Exact pentoxifylline RxCUI 8013 IN confirmed by current RxNorm. Oral extended-release 400 mg tablets for intermittent claudication; experimental immediate-release, intravenous and other-drug exposures are distinct.
Does not establish an interaction with every supplement, or transfer theophylline effects to caffeine. Occasional hypotension/arrhythmia reports were not more frequent than placebo in controlled trials. Immediate-release adverse-event results differ from extended-release.
Source 2: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 40 evaluable patients with type 2 diabetes and stable coronary artery disease receiving aspirin and clopidogrel.
No additional inhibition across the measured platelet-function assays.
How this applies: Interpret exact preparation, comparator and endpoint; no automatic combination causality.
Abstract-only; publisher body access failed 403. Short surrogate-endpoint study, no herbs and not proof of absence of rare clinical bleeding.
Source 3: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: A 71-year-old warfarin user plus spontaneous pharmacovigilance reports.
INR rose after the combination supplement dose increase; reports suggested a glucosamine-warfarin signal.
How this applies: Interpret exact preparation, comparator and endpoint; no automatic combination causality.
Abstract-only; confounding ingredients and warfarin changes. Does not isolate chondroitin or establish pentoxifylline interaction, absorption change or helpful spacing.
Source 4: Medication terminology
rxnav.nlm.nih.gov · Source check Sep 10, 2026
Population: Terminology.
Pentoxifylline, IN.
How this applies: Exact identity.
Not clinical evidence.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Sources checked and article drafted. | |
| Research summary published |
Article revision: b95f1cafa225e64f
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.